News
Pfizer buys Swiss preclinical stage firm Redvax
Pfizer has purchased a controlling stake in Redvax, a spin-off from Swiss biopharmaceutical firm Redbiotec. Terms of the transaction were not disclosed.Redvax is a preclinical stage company, which develops multi-component virus-like particles (VLPs) and other protein...
News
US researchers claim random mutations are responsible for certain cancers
Scientists from US-based Johns Hopkins Kimmel Cancer Centre have developed a statistical model, which measures the proportion of cancer incidence across many tissue types caused by random mutations. Random mutations occur when stem cells divide.Johns Hopkins...
News
Mylan and Gilead partner for TAF-based HIV treatments in developing markets
Mylan Laboratories has signed an agreement with Gilead Sciences to increase access to Tenofovir Alafenamide (TAF) based HIV treatments in developing countries. Mylan received non-exclusive rights to manufacture and distribute TAF as both a single agent...
News
AstraZeneca (AZ) and Eli Lilly have started AMARANTH, a phase II/III study investigating a potential treatment for early Alzheimer’s disease.
The trial will examine oral beta secretase cleaving enzyme (BACE) inhibitor AZD3293, also known as LY3314814, which reduced levels of amyloid-beta in the cerebro-spinal fluid of Alzheimer's patients and healthy volunteers in phase I studies. Other...
News
Pfizer establishes gene therapy unit for rare disease research
Researchers at Washington University School of Medicine in St. Louis, US, have reported preliminary data from a small clinical trial of a new breast cancer vaccine. Led by Washington University breast cancer surgeon and senior author...
News
EFPIA hails joint action on counterfeit drugs
The pan-European medicines verification system uses an anti-tampering device together with 2D barcoding to verify the authenticity of medicinal products and is currently being implemented with all supply chain stakeholders in Europe. It is being introduced...
News
Washington University-developed new breast cancer vaccine shows promise
Researchers at Washington University School of Medicine in St. Louis, US, have reported preliminary data from a small clinical trial of a new breast cancer vaccine. Led by Washington University breast cancer surgeon and senior...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















